Influence of Angiotensin-converting Enzyme Genetic Polymorphism on Late Renal Dysfunction After Adult-to-adult Living-donor Liver Transplantation

2016 ◽  
Vol 48 (4) ◽  
pp. 1184-1189
Author(s):  
T. Matsui ◽  
M. Usui ◽  
K. Fujinaga ◽  
K. Nakatani ◽  
Y. Iizawa ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Genetic Polymorphism ◽  
Angiotensin Converting Enzyme ◽  
Renal Dysfunction ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Converting Enzyme ◽  
Donor Liver ◽  
Donor Liver Transplantation

Impact of Advanced Renal Dysfunction on Posttransplant Outcomes After Living Donor Liver Transplantation in the United States

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Therese Bittermann ◽  
Peter L. Abt ◽  
Kim M. Olthoff ◽  
Navpreet Kaur ◽  
Julie K. Heimbach ◽  
...  
Keyword(s):  
United States ◽  
Liver Transplantation ◽  
Renal Dysfunction ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
The United States ◽  
Donor Liver ◽  
Donor Liver Transplantation

Early Postoperative Renal Dysfunction in the Adult Living Donor Liver Transplantation

2007 ◽  
Vol 39 (5) ◽  
pp. 1517-1519 ◽  
Author(s):  
S.K. Lee ◽  
J.B. Park ◽  
S.-J. Kim ◽  
G.S. Choi ◽  
D.J. Kim ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Renal Dysfunction ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Donor Liver Transplantation

Adult-to-Adult Living-Donor Liver Transplantation

Swiss Surgery ◽  
2003 ◽  
Vol 9 (5) ◽  
pp. 227-236 ◽  
Author(s):  
Majno ◽  
Mentha ◽  
Berney ◽  
Bühler ◽  
Giostra ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Therapeutic Option ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Multidisciplinary Program ◽  
First Case ◽  
Living Donor Transplantation ◽  
The Right

Living donor liver transplantation is a relatively new procedure in which the right side of the liver is harvested in a healthy donor and transplanted into a recipient. After the first case in 1994, over 3000 cases have been done worldwide. This review summarizes the reasons why the procedure is needed, describes its main technical aspects, highlights the boundaries in which it can be done safely, summarizes the current experience worldwide and describes the main points of the program in our unit. We argue that living-donor transplantation is a viable alternative to a long time on the waiting list for several patients, and it can be performed safely and successfully provided that all precautions are undertaken to minimize the risks in the donor and to increase the chances of a good outcome in the recipients. If these prerequisites are met, and within the framework of a structured multidisciplinary program, we believe that living-donor liver transplantation should be funded by health insurances as a recognized therapeutic option.

Sign in / Sign up

Export Citation Format

Share Document